Christopher Thunander - 15 Feb 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Reporting relationship: Chief Accounting Officer
Issuer ticker: N/A
Reported as of: 15 Feb 2022
Net transaction value: +$59,784
SEC form: 4
Accepted by SEC: 16 Feb 2022, 10:46:04 UTC
Prior SEC filing: 01 Oct 2021
Next SEC filing: 17 Aug 2022
Source filing: View source filing
Reporting owner signature: by Jessica Rumschlag as attorney in fact

Key filing fact

Christopher Thunander filed Form 4 for SURGALIGN HOLDINGS, INC. on 16 Feb 2022.

Key facts

This page summarizes Christopher Thunander's Form 4 filing for SURGALIGN HOLDINGS, INC..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Feb 2022, 10:46.

Change

Previous filing in this sequence was filed on 01 Oct 2021.
Current net transaction value: +$59,784.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRGA transaction

Common Stock

Award

Transaction value: $59,774
Shares: +130,000
Change %: +59%
Price: $0.4598
Shares after: 349,199
Date: 15 Feb 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRGA transaction Derivative

Warrants (right to buy)

Purchase

Transaction value: $9.75
Shares: +97,500
Change %
Price: $0.000100^*
Shares after: 97,500
Date: 15 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 97,500
Exercise price: $0.6000

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Total shares includes 17,985 shares purchased under the Company's Employee Stock Purchase Plan on December 31, 2021, which is exempt under Rule 16b-3(c).